-
Darigabat (developmental code
names CVL-865, PF-06372865, PF-6372865) is a
GABAergic medication which is
under development for the
treatment of photosensitive...
-
developmental disorders and
Angelman syndrome. It is
under development by Roche.
Darigabat "Alogabat - Genentech". AdisInsight. 28 June 2024.
Retrieved 29 October...
- TGW00AA (FKW00GA) – 5-HT1A
receptor agonist, 5-HT2A
receptor antagonist Darigabat (PF-06372865) –
GABAA receptor positive allosteric modulator Tebideutorexant...
-
sodium bromide)
Carbamazepine Chloralose Chlormezanone Clomethiazole Darigabat DEABL Deuterated etifoxine Dihydroergolines (e.g., dihydroergocryptine...
-
sodium bromide)
Carbamazepine Chloralose Chlormezanone Clomethiazole Darigabat DEABL Deuterated etifoxine Dihydroergolines (e.g., dihydroergocryptine...
-
sodium bromide)
Carbamazepine Chloralose Chlormezanone Clomethiazole Darigabat DEABL Deuterated etifoxine Dihydroergolines (e.g., dihydroergocryptine...
-
sodium bromide)
Carbamazepine Chloralose Chlormezanone Clomethiazole Darigabat DEABL Deuterated etifoxine Dihydroergolines (e.g., dihydroergocryptine...
-
sodium bromide)
Carbamazepine Chloralose Chlormezanone Clomethiazole Darigabat DEABL Deuterated etifoxine Dihydroergolines (e.g., dihydroergocryptine...
-
sodium bromide)
Carbamazepine Chloralose Chlormezanone Clomethiazole Darigabat DEABL Deuterated etifoxine Dihydroergolines (e.g., dihydroergocryptine...
-
sodium bromide)
Carbamazepine Chloralose Chlormezanone Clomethiazole Darigabat DEABL Deuterated etifoxine Dihydroergolines (e.g., dihydroergocryptine...
